Treatment of H. pylori infection;Le traitement de l'infection par Helicobacter pylori

Presse Medicale

Volumn 25, Issue 39, 1996, Pages 1917-1922

  De Korwin, J D ^a   Lozniewski, A ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; TETRACYCLINE; TINIDAZOLE;

DRUG EFFICACY; DRUG LEGISLATION; DUODENUM ULCER; FRANCE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; PATIENT COMPLIANCE; REVIEW; STOMACH ULCER;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH; STOMACH ULCER;

EID: 0030444248     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. De Korwin JD. Les pathologies associées à l'infection par Helicobacter pylori. Ann Institut Pasteur 1995; 6:192-8.
2. Labigne A. Pouvoir pathogène de H. pylori. Ann Institut Pasteur 1995; 6:167-78.
3. NIH consensus development panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272:65-9.
4. Conférence de consensus - Maladie ulcéreuse et gastrites à l'heure d'Helicobacter pylori. Conclusions et recommandations du jury. Gastroenterol Clin Biol 1996; 20:S155-62.
5. Talley NJ, Ormand JE, Frie CA, Zinsmeister AR. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia and health. Am J Gastroenterol 1992; 87:590-4.
6. Lozniewski A, de Korwin JD. Antibiotiques - Pharmacologie dans l'estomac. In: Helicobacter pylori, Mégraud F, Lamouliatte H eds. Collection Option Bio, Elsevier, 1996, Vol. 2 (sous presse).
7. Glupczynski Y. Détermination de la sensibilité de Helicobacter pylori aux agents antibactériens : base pour le traitement ou obsession du microbiologiste ? La Lettre de l'Infectiologue 1993; 5:190-5.
8. De Korwin J D. Les effets bénéfiques non prédits des macrolides en pathologie gastroduodénale : le traitement de l'infection à Helicobacter pylori. La Lettre de l'Infectiologue 1996; Hors série (septembre):9-14.
9. Glupczynski Y. Fréquence actuelle et implications cliniques de la résistance de Helicobacter pylori aux antibiotiques. Ann Institut Pasteur 1995; 6:216-23.
10. European Study Group on Antibiotic Susceptibility of Helicobacter pylori. Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1992; 11:777-81.
11. Van Zwet AA, Thijs JC, De Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995; 39:250-2.
12. Gustavson LE, Kaiser JF, Edmond AL, Locke CS, De Bartolo ML, Schneck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995; 39:2078-83.
13. McNulty CAM, Dent JC, Ford GA, Wilkinson SP. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa. J Antimicrob Chemother 1988; 22:729-38.
14. Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother 1993; 37:1506-9.
15. Veldhuyzen van Zanten SLO, Goldie J, Hollingsworth J, Silletti C, Richardson H, Hunt RH. Secretion of intravenously administered antibiotics in gastric juice: implications for the management of Helicobacter pylori. J Clin Pathol 1992; 45:225-7.
16. Westblom TU, Duriex DE. Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Dig Dis Sci 1991; 36:25-8.
17. Cardaci G, Lambert JR, King RG, Onishi N, Midolo P. Reduced amoxicillin uptake into human gastric mucosa when gastric juice pH is high. Antimicrob Agents Chemother 1995; 39:2084-7.
18. Cayla R. Comment éradiquer Helicobacter pylori ? Gastroenterol Clin Biol 1996; 20 (1 bis):S119-30.
19. Deltenre M, De Koster E, Caucheteur B, Otero J, Jonas C. Comment éradiquer Helicobacter pylori en 1995 ? Revue critique des traitements disponibles. Gastroenterol Clin Biol 1996; 20 (1 bis):S44-52.
20. Spadaccini A, De Fanis C, Sciampa G, et al. Omeprazole versus ranitidine: short-term triple therapy in patients with Helicobacter pylori - positive duodenal ulcers. Aliment Pharmacol Ther 1996; 10:829-83
21. McGowan C, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology 1996; 110:926-38.
22. Hosking WS, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343:508-10.
23. Penston JG. Review article; clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996; 10:469-86.
24. De Korwin JD. Dyspepsie non ulcéreuse et infection à Helicobacter pylori. In: Helicobacter pylori, Mëgraud F, Lamouliatte H eds. Collection Option Bio, Elsevier, 1996, Vol. 2 (sous presse).
25. Kuipers EJ, Lundell L, Klinkenbergknol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334:1018-22.